Last updated on July 2019

Effects of Oral Sildenafil on Mortality in Adults With PAH


Brief description of study

This is a blinded study in adult patients with PAH evaluating the relative effects of sildenafil on mortality when administered at the three doses (80 mg, 20 mg or 5 mg, all three times per day [TID]). In addition, the relative effects on clinical worsening and 6-minute walking distance (6MWD) will be assessed.

Clinical Study Identifier: NCT02060487

Find a site near you

Start Over

The Emory Clinic

Atlanta, GA United States
  Connect »

Spectrum Health Hospitals

Grand Rapids, MI United States
  Connect »

Spectrum Health

Grand Rapids, MI United States
  Connect »

Robert V. Sibilia MD, Inc.

Wooster, OH United States
  Connect »

St. Vincent's Hospital

Darlinghurst, Australia
  Connect »

Westmead Hospital

Westmead, Australia
  Connect »

BH Heart Center Tuzla

Tuzla, Bosnia and Herzegovina
  Connect »

Clinical Center University Sarajevo

Sarajevo, Bosnia and Herzegovina
  Connect »

Queen Mary Hospital

Hong Kong, Hong Kong
  Connect »

Prince of Wales Hospital

Shatin, New Territories, Hong Kong
  Connect »

Center of Chest Diseases

Johannesburg, South Africa
  Connect »

Dr PG Williams Practice

Johannesburg, South Africa
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.